ESTIMATION OF THE MODERN MUCOLYTIC THERAPY EFFICACY IN CHILDREN, SUFFERING FROM MUCOVISCIDOSIS (TWO YEAR EXPERIENCE OF DORNASE ALFA APPLICATION)
Complications from the part of the respiratory apparatus are the main reason for the lethality among patients, suffering from mucoviscidosis. The adequate mucolytic therapy is of great importance in the complex treatment of the chronic bronchopulmonary process. In 2004, in Omsk center of mucoviscido...
Saved in:
| Main Authors: | E.B. Pavlinova, A.G. Mingairova, T.I. Safonova, T.Yu. Korneyeva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2007-03-01
|
| Series: | Вопросы современной педиатрии |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/1058 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A MUCOLYTIC WITH ANTIINFLAMMATORY QUALITIES FOR CHILDREN SUFFERED FROM CYSTIC FIBROSIS: DORNASE ALFA
by: O. I. Simonova, et al.
Published: (2012-12-01) -
ROLE OF THE KNOWN MUCOLYTICS IN MUCOVISCIDOSIS THERAPY
by: O. I. Simonova, et al.
Published: (2014-11-01) -
DORNASE ALFA: WHAT EFFECTIVENESS OF MEDICATION DEPENDS ON?
by: O.I. Simonova
Published: (2009-07-01) -
PECULIARITIES OF DORNASE ALFA AND KINESITHERAPY USE IN CHILDREN WITH CYSTIC FIBROSIS
by: O. I. Simonova
Published: (2013-07-01) -
Use of dornase alfa in the management of life-threatening mucostasis in airway stents: its efficacy and safety
by: Demet Turan, et al.
Published: (2025-02-01)